Events

Oncoinvent will present the company to investors during JP Morgan Healthcare Conference

CEO, Anders Månsson and CFO, Tore Kvam will present Oncoinvent to investors during the JP Morgan 42nd Annual Healthcare Conference

Organiser:
Venue:

San Francisco


Date: January 8, 2024 12:00 am

Oncoinvent to present at DNB Nordic Healthcare Conference 2023

CEO, Anders Månsson will present Oncoinvent at the DNB Nordic Healthcare Conference 2023

Organiser: DNB
Venue:

Dronning Eufemias gate 30, Oslo, Norway


Date: December 14, 2023 12:35 pm
Program

Nordic- American Healthcare Conference 2023

Oncoinvent will be presenting the company at the Nordic American Healthcare Conference 2023. The company will be represented by CEO Anders Månsson and CFO Tore Kvam

Organiser: DNB / Back Bay
Venue:

Shearman & Sterling, 599 Lexington Ave, New York City


Date: December 6, 2023 9:45 am
Program

Oncoinvent at Nordic Life Science Days

CEO, Anders Månsson will be at the Nordic Life Science Days in Copenhagen

Organiser:
Venue:

Bella Center – Copenhagen


Date: November 28, 2023 8:00 am
Program

Presentation of Q3 results including outlook

Oncoinvent would like to extend an invitation to a short update on the company and a presentation on Q3 report including outlook. The presentation will be held on Thursday 23. November 2023 at 10:00 AM in the offices of Carnegie, Fjordalléen 16, Oslo, 5. floor, Meeting room: Verftet. It will also be possible to attend virtually.

To attend, please register with ir@oncoinvent.com. Logon details will be distributed to registered attendees.


Oncoinvent ønsker med dette å invitere til en kort status oppdatering og presentasjon av 3. kvartal inkludert veien videre. Presentasjonen vil holdes torsdag 23. november 2023, kl. 10:00 i lokalene til Carnegie, Fjordalléen 16, Oslo, 5. Etasje, Møterom: Verftet Det vil også være mulig å delta virtuelt.

Vi ber om at deltakere registrerer seg ved å sende en e-post til ir@oncoinvent.com. Eventuelle påloggingsdetaljer vil distribueres deretter.

Organiser: Oncoinvent / Carnegie and DnB
Venue:

Carnegie, Fjordalléen 16, Oslo, 5. floor,
Meeting room: Verftet.


Date: November 23, 2023 10:00 am

Oncoinvent will be attending Bio-Europe

Oncoinvent will be attending Bio-Europe in Munich November 6th to 8th and have meetings with investors.

Organiser:
Venue:
Date: November 6, 2023 12:00 am
Program

Hadean Ventures Annual Showcase

Oncoinvent will present the company at the Hadean Ventures annual showcase.

Organiser: Hadean Venture
Venue:

Oslo, Norway


Date: October 26, 2023 10:00 am

Oncoinvent presented the company at podcast Radium

CEO, Anders Månsson and CFO, Tore Kvam presented Oncoinvent at the Radforsk’s podcast Radium episode 284. The podcast can be heard HERE (norwegian)

 

Organiser: Radforsk
Venue:

Virtual


Date: October 17, 2023 12:30 pm
Program

Oncoinvent to present at the LSX Nordic Congress, Copenhagen

CEO, Anders Månsson presentes Oncoinvent at the LSX conference and meet with investors.

Organiser: LSXNordic
Venue:

Bella Sky, Center Blvd. 5, 2300 Copenhagen Denmark


Date: October 10, 2023 12:00 am
Program

Oncoinvent will present at the 13th PSOGI Congress 2023

Oncoinvent will present at the 13th PSOGI Congress:

CMO, Kari Myren will present at the poster session: Title: “Novel radiopharmaceutical for intraperitoneal treatment of peritoneal metastasis from colorectal and ovarian cancer after complete surgical resection”,

Dr. Stein Gunnar Larsen, Oslo University Hospital will also present an oral abstract: Title: “18-month safety and efficacy after intraperitoneal treatment with 224Radium-labelled microparticles (Radspherin) after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for colorectal peritoneal metastasis (PM)”

Organiser: PSOGI - Peritoneal Surface Oncology Group International
Venue:

October 4th-6th, 2023, Venice, Italy


Date: October 4, 2023 11:55 am
Program

BioStock: Oncoinvent in emerging hot spot in oncology, interview with Anders Månsson (CEO)

Anders Månsson recently visited BioStock Studio to talk about his new role as CEO of Oncoinvent. The full interview is available at: Interview with Anders Månsson

 

Organiser: BioStock
Venue:

Virtual


Date: October 2, 2023 9:00 am
Program

Fireside chat with Truist’s Securities

Senior management of Oncoinvent will be participating in a virtual fireside chat with biotech analyst Nicole Germino at Truist Securities

Organiser: Truist Securities
Venue:

Virtual – HERE


Date: September 29, 2023 4:00 pm
Program

Oncoinvent will participate at the ESGO 2023 congress

Oncoinvent be represented by CMO, Dr. Kari Myren at the 2023 ESGO congress.

There will also be a mini oral presentation on the theme “First Experience With Intra-Abdominal 224Radium-Labelled Microparticles (Radspherin) After Cytoreductive Surgery For Peritoneal Metastasis In Recurrent Epithelial Ovarian Cancer (Phase 1 Study)” by Dr. Els Van Nieuwenhuysen, University Hospital Leuven, Leuven, Belgium

Organiser: ESGO - European Congress of Gynaecological Oncology
Venue:

The congress venue is situated at the Istanbul Congress Center (ICC), Türkiye


Date: September 29, 2023 12:00 am
Program

Oncoinvent will participate at the EANM 23 conference

Oncoinvent will be at the EANM conference in Vienna from September 9th – 13th

Organiser: EANM
Venue:

Vienna


Date: September 9, 2023 12:00 am
Program

Oncoinvent to Present at TD Cowen Radiopharmaceutical Innovation Summit

Oncoinvent will participate in a virtual fireside chat at the TD Cowen Radiopharmaceutical Innovation Summit on Tuesday, June 20, 2023, at 9:30 a.m. ET.

Organiser: TD Cowen
Venue:

Virtual


Date: June 20, 2023 3:30 pm

Oncoinvent to present at Guggenheim Radiopharmaceuticals Day conference

CEO, Jan Alfheim will present Oncoinvent at the Guggenheim Radiopharmaceuticals Day conference and have 1×1 meetings with investors togheter with CFO, Tore Kvam

Organiser: Guggenheim
Venue:

Convene, 101 Park Avenue, New York



Date: May 15, 2023 9:00 am

Podcast – Stormkast, Valebrokk & Stordalen (Norwegian)

Organiser: Stormkast
Venue:
Date: March 15, 2023 12:00 am
Program

Oncoinvent Update

Oncoinvent would like to extend an invitation to a short update on the company. The presentation will be held on Friday 17. February 2023 at 09:00 AM in the company offices at Gullhaugsveien 7, Oslo, 3rd Floor. It will also be possible to attend virtually.

To attend, please register with kvam@oncoinvent.com.

————————————————–

Oncoinvent ønsker med dette å invitere til en kort status oppdatering. Presentasjonen vil holdes Fredag 17. februar 2023, kl. 09:00 i selskapets lokaler i Gullhaugsveien 7, Oslo, 3. etasje. Det vil også være mulig å delta virtuelt.

Vi ber om at deltakere registrerer seg ved å sende en e-post til kvam@oncoinvent.com.

Organiser: Oncoinvent
Venue:

Gullhaugveien 7, Oslo / Virtual


Date: February 17, 2023 9:00 am

Oncoinvent to present at B. Riley Securities’ 3rd Annual Oncology Conference

Organiser: B. Riley Securities
Venue:

CEO, Jan Alfheim will be presenting Oncoinvent at the virtual B. Riley Securities’ 3rd Annual Oncology Conference on Wednesday 18th of January 2023 at 19:00 CET (01:00 PM ET). For more info please see https://brileyoncology22.sequireevents.com/.

 


Date: January 18, 2023 7:00 pm
Program

DNB’s 13th annual Nordic Healthcare Conference 2022

Organiser: DNB
Venue:

Oncoinvent AS, a clinical stage radiopharmaceutical company, announces that its CEO, Jan A. Alfheim will present the company at DNB’s 13th annual Nordic Healthcare Conference 2022 on 15th of December 2022. The presentation will take place from 09:50-10:10 CET in the Market Session Room C2.


Date: December 15, 2022 9:50 am
Program

4th Targeted Radiopharmaceuticals Europe

CEO of Oncoinvent, Jan A. Alfheim, will be presenting the company at the 4th Targeted Radiopharmaceuticals Europe December 7 at 14:30

Organiser:
Venue:

Leonardo Royal Amsterdam
Paul van Vlissingenstraat 24
1096 BK
Amsterdam
Netherlands


Date: December 7, 2022 2:45 pm
Program

Next Generation Nordic Life Science Champions

CFO of Oncoinvent, Tore Kvam, will be presenting the company at Carnegie Nordic Life Science Champions Seminar December 7 at 14:30

Organiser: Carnegie
Venue:

Virtual


Date: December 7, 2022 2:30 pm
Program

Norwegian Oncology Lunch Seminar

CEO of Oncoinvent, Jan A. Alfheim, will be presenting the company at ABGSC Norwegian Oncology Seminar November 23 at 12:50

Organiser: ABG Sundal Collier
Venue:

ABG Sundal Collier
Ruseløkkveien 26, 8th floor.
Oslo


Date: November 23, 2022 12:50 pm

Dosimetry data from the Phase I expansion cohort of Radspherin® in colorectal cancer patients to be presented at the 2022 EANM Annual Meeting

The aim of this study was to estimate the absorbed doses to normal tissues for patients injected intraperitoneally with a suspension of radium-224 adsorbed in calcium carbonate microparticles (224Ra-CaCO3-MP) for treating peritoneal carcinomatosis originating from colorectal cancer.

Organiser: EANM 2022
Venue:

CCIB – Centre de Convencions Internacional
de Barcelona / Barcelona International
Convention Centre
Hall 111

e-Poster Presentation Session 11 – Dosimetry

Committee: Dosimetry – Novel Tracers and Computer-Based Modelling


Date: October 18, 2022 3:00 pm
Program

Oncoinvent to present at the LSX Nordic biotech congress

CEO, Jan A. Alfheim, will be speaking at the LSX Nordic Biotech Congress and host 1-on-1 meetings with investors on 6-7 September, 2022

Organiser: LSXNordic
Venue:

Bella Sky, Center Blvd. 5, 2300 Copenhagen, Denmark


Date: September 6, 2022 12:00 am
Program

Invitation to a Presentation of the 1st Quarter 2022 Results

Oncoinvent would like to extend an invitation to a presentation of the Q1 2022 results. The presentation will be held on Wednesday 1. June 2022 at 08:30 AM in the offices of the company at Gullhaugsveien 7, Oslo, 3rd Floor.

To attend, please register with kvam@oncoinvent.com.


Oncoinvent ønsker med dette å invitere til presentasjon av resultater for 1. kvartal 2022. Presentasjonen vil holdes onsdag 1. juni 2022, kl. 08:30 i selskapets lokaler i Gullhaugsveien 7, Oslo, 3. etasje.

Vi ber om at deltakere registrerer seg ved å sende en e-post til kvam@oncoinvent.com.

Organiser: Oncoinvent
Venue:

Gullhaugsveien 7, Oslo, 3rd Floor.


Date: June 1, 2022 8:30 am

DNB’s Small & Medium Enterprises Conference 2022

CEO, Jan A. Alfheim, will present Oncoinvent at the DNB Small & Medium Enterprises Conference and host 1-on-1 meetings with investors on April 7, 2022

Organiser: DNB
Venue:

Dronning Eufemias gate 30, Oslo, Norway


Date: April 7, 2022 9:50 am
Program

Oncoinvent to participate in the 2022 Credit Suisse London Healthcare Conference

Organiser: Credit Suisse
Venue:

Company management will participate in 1×1 meetings


Date: March 2, 2022 12:00 am
Program

Oncoinvent to participate in the B. Riley Radiation-Oncology Investor Day

Organiser: B. Riley Financial, Inc.
Venue:

Oncoinvent will participate in fireside chat in the B. Riley Radiation Oncology Investor Day


Date: February 22, 2022 4:30 pm
Program

Oncoinvent to present at DNB’s 12th Nordic Healthcare Conference

Organiser: DNB
Venue:

Oncoinvent AS, a clinical stage company advancing a pipeline of radiopharmaceutical products across a variety of solid cancers, announces that its CEO, Jan A. Alfheim will present the company at a live webcast at DNB’s 12th Nordic Healthcare Conference on 16 December 2021. The presentation will take place from 10:45-11:05 CET.


Date: December 16, 2021 10:45 am
Program

Invitation to a Presentation of the 3 Quarter 2021 Results

Oncoinvent would like to extend an invitation to a presentation of the Q3 2021 results. The presentation will be held virtually via Teams at 09:00 on Friday 12. November 2021.

We request that participants register with kvam@oncoinvent.com for logon details.

Organiser: Oncoinvent
Venue:

Virtual on Teams


Date: November 12, 2021 9:00 am

34th Annual Congress of the European Association of Nuclear Medicine

Oncoinvent to present four posters at the 34th Annual Congress of the European Association of Nuclear Medicine

Organiser: European Association of Nuclear Medicine
Venue:

Virtual


Date: October 20, 2021 12:00 am
Program

Invitation to a Presentation of the 2 Quarter 2021 Results

Oncoinvent would like to extend an invitation to a presentation of the Q2 2021 results. The presentation will be held virtually via Teams at 09:00 on Thursday 9. September 2021.

We request that participants register with kvam@oncoinvent.com for logon details.

Organiser: Oncoinvent AS
Venue:

Virtual


Date: September 9, 2021 9:00 am

Stern IR: Virtual meetings during J.P. Morgan 2021 Health Conference January 11-14, 2021

Virtual Event organized by Stern IR at time of J.P. Morgan 2021 Health Conference: January 11-14, 2021

Oncoinvent CEO, Jan A. Alfheim will present the company at Stern IR’s  event that is scheduled to occur during the virtual J.P. Morgan Healthcare Conference . The presentation is awailable at https://wsw.com/webcast/sternir/oncoi/2294600.

 

Organiser: Stern IR
Venue:

Virtual


Date: January 11, 2021 1:00 pm
Program

Invitation to a Presentation of the 3. Quarter 2020 Results

Oncoinvent would like to extend an invitation to a presentation of the Q3 2020 results. The presentation will be held virtually at 10:00 on Friday 23. October 2020. We request that participants register with kvam@oncoinvent.com for logon details.

The quarterly report will be made available on www.oncoinvent.com on the 23. October 2020.

Organiser: Oncoinvent AS
Venue:

Virtual


Date: October 23, 2020 10:00 am

Oncoinvent to present a e-poster at the European Association of Nuclear Medicine (EANM) Congress

Oncoinvent will present the e-poster “Size-controlled 224Ra-labelled calcium carbonate microparticles against peritoneal carcinomatosis” at the virtual 33rd annual European Association of Nuclear Medicine (EANM) Congress. The abstract (no. EP-290) can be downloaded here.

Organiser: European Association of Nuclear Medicine
Venue:

Virtual


Date: October 22, 2020 12:00 pm
Program

Oncoinvent to present at Nordic American Life Science Conference 2020

Oncoinvent CEO, Jan A. Alfheim will present the company at the virtual Nordic American Life Science Conference.

Organiser: Nordic American Lifscience
Venue:

Virtual


Date: October 22, 2020 10:10 am
Program

Oncoinvent presented at Hadean Ventures Annual Event 2020

Oncoinvent CEO, Jan A. Alfheim presented the company at the virtual Hadean Ventures Annual Event 2020. The presentation is available here (https://www.youtube.com/watch?v=f_cJUHC4vSg&feature=emb_logo).

 

 

Organiser: Hadean Ventures
Venue:

Virtual


Date: October 21, 2020 12:00 pm

Oncoinvent to present at DNB Nordic Healthcare Conference 2019

Oncoinvent CEO, Jan A. Alfheim will present the company at the DnB Nordic Healthcare Conference 2019 at the venture session for scaleups.

Organiser: DnB
Venue:

Audioturium 1

Dronning Eufemias gate 30,

Oslo, Norway


Date: December 12, 2019 3:35 pm
Program

Oncoinvent to present at Nordic American Life Science Conference 2019

Oncoinvent CEO, Jan A. Alfheim will present the company at the Nordic American Life Science Conference in New York, USA 

Organiser: Nasdaq, DNB, Business Sweden
Venue:

Well Said, Convene, 151 West 42nd Street, New York, NY 10036


Date: December 5, 2019 2:30 pm
Program

Invitation to a Presentation of the Third Quarter 2019 Results

Oncoinvent would like to extend an invitation to a presentation of the Q3 2019 results. The presentation will be held at 14:00 on Thursday 31. October 2019 in the company offices at Gullhaugsveien 7, Oslo, 2nd Floor.

To attend, please register with 

kvam@oncoinvent.com

The quarterly report will be made available on www.oncoinvent.com on the 31. October 2019

Organiser: Oncoinvent AS
Venue:

Gullhaugsveien 7, Oslo


Date: October 31, 2019 2:00 pm
Program

Outsourcing in Clinical Trials and Clinical Trial Supply Nordics

Head of Clinical Operations at Oncoinvent, Helen Johansen Blanco will be presenting at the conference “Outsourcing in Clinical Trials and Clinical Trial Supply Nordics”.

Organiser: Arena Event International
Venue:

Scandic Copenhagen, Denmark

 


Date: October 22, 2019 3:00 pm
Program

European Association of Nuclear Medicine (EANM) 2019

CSO Tina Bønsdorff, presented the ePoster «Feasibility of Ra-224 SPECT CT imaging in a therapeutic setting – a phantom study» developed by Stokke (PhD, Assoc. Prof) and Mikalsen (PhD) at Oslo University Hospital, Oslo, NORWAY, at the European Association of Nuclear Medicine (EANM) annual conference held in Barcelona.

Organiser: European Association of Nuclear Medicine (EANM)
Venue:

CCIB – Centre de Convencions Internacional de Barcelona,
Placa de Willy Brandt, 11-14
08019 Barcelona, Spain


Date: October 16, 2019 12:00 am
Program

Presentation of the Second Quarter 2019 Results

Oncoinvent would like to extend an invitation to a presentation of the Q2 2019 results. The presentation will be held at 15:00 on Thursday 29. August 2019 in the company offices at Gullhaugsveien 7, Oslo, 2nd Floor.

Going forward quarterly result presentations will be held on a regular basis.

To attend, please register with
kvam@oncoinvent.com

The quarterly report will be made available on www.oncoinvent.com on the 29. August 2019

Organiser: Oncoinvent AS
Venue:

Gullhaugsveien 7, Oslo


Date: August 29, 2019 3:00 pm
Program

Oncoinvent to present poster at the SNMMI 2019 Annual Meeting

Oncoinvent researcher Elisa Napoli will present the poster “A primary activity standard for the alpha-emitting radionuclide Ra-224” at the SNMMI 2019 Annual Meeting.

Organiser: Society of Nuclear Medicine & Molecular Imaging
Venue:

SNMMI 2019 Annual Meeting, Anaheim, CA


Date: June 25, 2019 12:00 am
Program

Oncoinvent to present at ABGSC Norwegian Biotech Oncology Seminar

Jan A. Alfheim, CEO of Oncoinvent will give a short status presentation about the company at the ABG Sundal Collier’s Norwegian Biotech Oncology Seminar

Organiser: ABGSC
Venue:

ABG Sundal Collier, Munkedamsveien 45E, 7th floor, Oslo, Norway


Date: June 11, 2019 11:00 am
Program

Oncoinvent to present at International Cancer Cluster Showcase

Oncoinvent CEO Jan A. Alfheim will be presenting the company during the International Cancer Cluster Showcase at the BIO International Convention 2019.

Organiser: BIO International
Venue:

BIO International, Pennsylvania Convention Center, Room : 204B, level 200, 1101 Arch St, Philadelphia, PA 10107, USA


Date: June 3, 2019 12:00 am
Program

Oncoinvent to present at the Venture Session of DNB’s 8th Annual Nordic Healthcare Conference 2017

Oncoinvent CEO Jan A. Alfheim will be presenting at 10:25 during the morning Venture Session on Thursday the 14th of December

Organiser: DnB
Venue:

DNB Bank, Dronning Eufemias Gate 30, Bjørvika, 0191 Oslo, Norway


Date: December 14, 2017 8:30 am
Program

Oncoinvent to present preclinical efficacy data in a poster session at the 20th Biennial Meeting of the European Society of Gynaecological Oncology (ESGO 2017)

The poster ‘Preclinical Evaluation of a Novel Alpha-Particle Emitting Therapeutic Agent for Intraperitoneal Therapy of Peritoneal Metastases’ by Oncoinvent scientists Tina B. Bønsdorff, Sara Westrøm, Øyvind S. Bruland and Roy H. Larsen will be presented at the congress.

Organiser: ESGO
Venue:

Austria Center Vienna, Bruno Kreisky Platz 1, Vienna, 1210 Austria


Date: November 4, 2017 9:30 am
Program

Oncoinvent to present at the 30th Annual Congress of the European Association of Nuclear Medicine – EANM

Researchers Sara Westrøm and Elisa Napoli will each be presenting findings of their research during the morning session on Sunday the 22nd of October

Organiser: EANM
Venue:

Austria Center Vienna, Bruno Kreisky Platz 1,Vienna, 1210 Austria


Date: October 21, 2017 8:00 am

Oncoinvent Update – Radforsk Podcast

Oncoinvent CEO Jan A. Alfheim speaks with Radforsk’s Jónas Einarsson and Elisabeth Kirkeng Andersen

Organiser: RADFORSK
Venue:

Ullernchausséen 64 – 66, 0379 Oslo, Norway


Date: October 18, 2017 12:00 am
Program

Oncoinvent to present at Partnership4Life Symposium

CEO Jan A. Alfheim will give a company presentation at the upcoming Partnership4Life symposium on February 15.

Organiser: The Life Science Cluster
Venue:

Forskningsparken, Gaustadaléen 21 Oslo, Norge


Date: February 15, 2017 12:00 pm
Program

DNB Health Care Conference

Organiser:
Venue:

DNB BANK, Dronning Eufemiasgate 30, Bjørvika, NO- 0191 Oslo


Date: December 15, 2016 8:30 am
Program

Anders Månsson

Chief Executive Officer

mansson@oncoinvent.com

+47 488 68 863

Anders Månsson is a business executive with over 25 years of experience from management roles in the pharmaceutical industry, focusing on commercialisation and M&A + licensing. Mr. Månsson has held leading roles in the industry both in his native Sweden and in other European countries, and he has worked extensively with the USA and Asia as focus markets in global roles.

Mr. Månsson holds a B.Sc. degree in Business & Economics from Lund’s University in Sweden as well as an MBA from Business School Lausanne in Switzerland. He has a broad-based industrial experience, featuring both large multinational companies such as Meda, Ferring & LEO Pharma, and including leading roles in start-ups and smaller biotech companies. On top of his executive role in Oncoinvent, Mr. Månsson holds two non-executive director positions serving on the board of EQL Pharma AB as well Immetric AB, the latter being an investment company focusing on life science.